The Babak Lab HK
@Babaklab
Followers
837
Following
111
Media
283
Statuses
508
Integrating chemistry, molecular biology and experimental oncology
Hong Kong
Joined June 2020
Today we welcome our new undergraduate student Albert! 😁 We’re looking forward to working together and seeing him grow in our lab. #NewStudent #UndergraduateResearch #LabLife
0
0
5
🇧🇷 14 Nov — UFRJ Today at 14:00 & 16:00, we’ll be at @ufrj the final stop of our Brazil visit — join us to learn about fully funded PhD opportunities at CityUHK. #CityUHK #PhDopportunities #UFRJ #HKPFS #Brazil #StudyAbroad
0
0
1
🇧🇷 14 Nov — UFRJ Tomorrow at 14:00 & 16:00, we’re at @ufrj for the final day of our Brazil visit — sharing PhD opportunities at CityUHK. Great time at UNESP Bauru — now heading to Rio! #CityUHK #PhDopportunities #UFRJ #HKPFS #StudyAbroad #Brazil
0
0
4
New in @Nature: Nerve cells may support small-cell lung cancer (SCLC) growth and spread. In mice, blocking nerve signals slowed tumour progression. Link in the comments 👇 #CancerResearch #NatureJournal #Neuroscience #NeuroOncology #TumourMicroenvironment
1
0
0
We’re happy to share that City University of Hong Kong and UNICAMP have signed a Memorandum of Understanding (MoU) to support future academic exchange and collaboration. We look forward to building connections and working together on research and student opportunities.
0
1
5
🇧🇷🎓 11 Nov — USP São Carlos Today, 11 November at 14:00 and 16:00, we’re at USP São Carlos sharing details about PhD studies at City University of Hong Kong. Tomorrow at the same time, we’ll be visiting USP Bauru. Hope to see you there!
0
0
4
🇧🇷 Prof. Maria Babak from CityUHK is in Brazil this week to meet future PhD students and answer your questions about the Hong Kong PhD Fellowship. All key info is in the image — don’t miss the deadlines! 🔗 https://t.co/mZsD3JS7X3 | https://t.co/LjcODbh3ma
0
0
0
📸 Image generated using Sora by OpenAI. Article link:
thelancet.com
Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been increasingly developed and subsequently approved by the US Food and Drug Administ...
0
0
0
New in @TheLancet: Is subcutaneous immunotherapy a win for patients - or for pharma? A new commentary compares SC vs IV checkpoint inhibitors, raising concerns over pricing, patents, and biosimilar access. Link in the comments 👇 #Immunotherapy #PharmaEconomics #Biosimilars
1
0
0
We won 1st place! 🧠🏆 Our lab team took the top prize at quiz night - proving that sharp minds work just as well outside the lab. Proud of the team spirit, collaboration, and a great night of brainpower. See you at the next challenge! #LabLife #QuizChampions #ScienceAndFun
0
0
3
📸 Image generated using Sora by OpenAI. Article link:
nature.com
Nature Chemistry - STING is a promising drug target, but selective activation is necessary for safety and efficacy. Researchers have developed a two-component prodrug system for potent...
0
0
0
New in @NatureChemistry: A tumour-specific STING agonist activated only by local enzymes (β-glucuronidase) in the tumour microenvironment. ➤ Potent immune response ➤ Minimal systemic toxicity A smarter way to do immunotherapy. Link in comments 👇 #STING #CancerResearch
1
0
0
📸 Image generated using Sora by OpenAI. Article link:
nejm.org
The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because de...
0
0
0
New in @NEJM: 23-year ERSPC follow-up in NEJM shows PSA screening reduces prostate cancer mortality by 13%. But: 456 men must be screened to prevent 1 death. Balance needed between early detection and overtreatment. Link in the comments 👇 #ProstateCancer #CancerScreening
1
0
0
Happy Halloween from our lab! 🧪🎃 Wishing everyone a spooky season filled with science, sweets, and just the right amount of mystery. May your experiments be successful, your pipettes behave, and your pumpkins glow brightly! #HappyHalloween #LabLife #TrickOrTreat
1
0
5
📸 Image generated using Sora by OpenAI. Article link:
science.org
The premise of cancer immunotherapy is that cancers are specifically visible to an immune system tolerized to healthy self. The promise of cancer immunotherapy is that immune effector mechanisms and...
0
0
0
δ T cells are emerging as powerful tools in cancer immunotherapy. Unlike conventional T cells, they recognize stress signals and kill tumors directly. A new Science review highlights their off-the-shelf potential. Link in comments 👇 #Immunotherapy #CancerResearch
1
0
0